The Pluripotency Factor Musashi-2 Is a Novel Target for Lung Cancer Therapy
The Pluripotency Factor Musashi-2 Is a Novel Target for Lung Cancer Therapy
About this item
Full title
Author / Creator
Publisher
United States: American Thoracic Society
Journal title
Language
English
Formats
Publication information
Publisher
United States: American Thoracic Society
Subjects
More information
Scope and Contents
Contents
Previously we reported that mithramycin represses multiple pathways critical for stem cell signaling and pluripotency in lung cancer cells. This phenomenon coincided with decreased side population fraction and dramatic dose-dependent growth arrest of lung cancer cells in vitro and in vivo. In the present study, microarray, quantitative reverse tran...
Alternative Titles
Full title
The Pluripotency Factor Musashi-2 Is a Novel Target for Lung Cancer Therapy
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5946505
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5946505
Other Identifiers
ISSN
2329-6933
E-ISSN
2325-6621
DOI
10.1513/AnnalsATS.201707-608MG
